Skip to main content
Top
Published in: General Thoracic and Cardiovascular Surgery 2/2020

01-02-2020 | Case Report

Hypertrophic obstructive cardiomyopathy and mitral regurgitation in Libman–Sacks endocarditis

Authors: Go Yamashita, Naoki Kanemitsu, Yasuaki Nakashima, Takehiko Matsuo, Takeichiro Nakane, Masanori Honda, Hitoshi Okabayashi

Published in: General Thoracic and Cardiovascular Surgery | Issue 2/2020

Login to get access

Abstract

Hypertrophic obstructive cardiomyopathy in Libman–Sacks endocarditis is quite rare and the correct etiological relationship between them is unknown. Some changes may cause a secondary disorganization of the ordinary muscle structure, making a disarray pattern with irregular interwoven myocyte fibers. This case report describes one of the first cases of ventricular septal myectomy and mitral valve replacement for hypertrophic obstructive cardiomyopathy and mitral valve regurgitation associated with Libman–Sacks endocarditis.
Literature
1.
go back to reference Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med. 1924;33:701–37.CrossRef Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med. 1924;33:701–37.CrossRef
2.
go back to reference Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807–16.CrossRef Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807–16.CrossRef
3.
go back to reference Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270–6.CrossRef Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29:270–6.CrossRef
4.
go back to reference Arbustini E, Narula N, Tavazzi L, et al. The MOGE(S) classification of cardiomyopathy for clinicians. J Am Coll Cardiol. 2014;64:304–18.CrossRef Arbustini E, Narula N, Tavazzi L, et al. The MOGE(S) classification of cardiomyopathy for clinicians. J Am Coll Cardiol. 2014;64:304–18.CrossRef
5.
go back to reference Anastasiadis GP, Moyssakis I, Boki K, Kyriakidis M. Hypertrophic cardiomyopathy in systemic lupus erythematosus. Mayo Clin Proc. 2001;71:111.CrossRef Anastasiadis GP, Moyssakis I, Boki K, Kyriakidis M. Hypertrophic cardiomyopathy in systemic lupus erythematosus. Mayo Clin Proc. 2001;71:111.CrossRef
6.
go back to reference Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J. 1985;110:1257–65.CrossRef Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J. 1985;110:1257–65.CrossRef
7.
go back to reference Asherson RA, Ames D, Coltart J, Byrne C, Hughes GR. Hypertrophic cardiomyopathy in systemic lupus erythematosus and “lupus-like” disease. Chance association? A report of 2 cases. J Rheumatol. 1992;19:1973–7.PubMed Asherson RA, Ames D, Coltart J, Byrne C, Hughes GR. Hypertrophic cardiomyopathy in systemic lupus erythematosus and “lupus-like” disease. Chance association? A report of 2 cases. J Rheumatol. 1992;19:1973–7.PubMed
8.
go back to reference Kotani T, Takeuchi T, Sakamoto M, et al. A case of systemic lupus erythematosus associated with hypertrophic cardiomyopathy. Nihon Rinsho Meneki Gakkai Kaishi. 2005;28(6):413–7.CrossRef Kotani T, Takeuchi T, Sakamoto M, et al. A case of systemic lupus erythematosus associated with hypertrophic cardiomyopathy. Nihon Rinsho Meneki Gakkai Kaishi. 2005;28(6):413–7.CrossRef
9.
go back to reference Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335:1424.CrossRef Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335:1424.CrossRef
10.
go back to reference Kotkar KD, Said SM. Libman–Sacks endocarditis in a patient with antiphospholipid syndrome. Ann Thorac Surg. 2016;102:e31–2.CrossRef Kotkar KD, Said SM. Libman–Sacks endocarditis in a patient with antiphospholipid syndrome. Ann Thorac Surg. 2016;102:e31–2.CrossRef
Metadata
Title
Hypertrophic obstructive cardiomyopathy and mitral regurgitation in Libman–Sacks endocarditis
Authors
Go Yamashita
Naoki Kanemitsu
Yasuaki Nakashima
Takehiko Matsuo
Takeichiro Nakane
Masanori Honda
Hitoshi Okabayashi
Publication date
01-02-2020
Publisher
Springer Singapore
Published in
General Thoracic and Cardiovascular Surgery / Issue 2/2020
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-018-1042-7

Other articles of this Issue 2/2020

General Thoracic and Cardiovascular Surgery 2/2020 Go to the issue